Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection: A personal perspective of a worldwide epidemic

Expert Review of Dermatology

Volumn 1, Issue 5, 2006, Pages 631-637

  Cohen, Philip R ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845940506     PISSN: 17469872     EISSN: 17469880     Source Type: Journal    
DOI: 10.1586/17469872.1.5.631     Document Type: Article

References (38)

1. Marcinak JF, Frank AL. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Curr. Opin. Infect. Dis. 16, 265–269 (2003).
2. Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections – Los Angeles county, California, 2002–2003. MMWR 52, 88 (2003).
3. Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 21, 910–916 (2002).
4. Gosbell IB, Mercer JL, Neville SA et al. Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med. J. Aust. 174, 627–630 (2001).
5. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin. Proc. 80, 1201–1208 (2005).
6. Padmanabhan RA, Fraser TG. The emergence of methicillin-resistant Staphylococcus aureus in the community. Cleveland Clin. J. Med. 72, 235–241 (2005).
7. Niami TS, LeDell KH, Boxrud DJ et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996–1998. Clin. Infect. Dis. 33, 990–996 (2001).
8. Dietrich DW, Auld DB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in Southern New England children. Pediatrics 113, E347 –E352 (2004).
9. Eady EA, Cove JH. Staphyloccal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus – emerging problem for the management of skin and soft tissue infections. Curr. Opin. Infect. Dis. 16, 103–124 (2003)
10. Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS. Successful multiresistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J. Clin. Microbiol. 43, 4719–4730 (2005).
11. Baggett HC, Hennessy TW, Rudolph K et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J. Infect. Dis. 189, 1565–1573 (2004).
12. Crum NF. The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections. Scand. J. Infect. Dis. 37, 651–656 (2005).
13. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9, 978–984 (2003).
14. Cohen PR, Kurzrock R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J. Am. Acad. Dermatol. 50, 277–280 (2004).
15. Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr. Infect. Dis. J. 24, 457–458 (2005).
16. Cohen PR, Grossman ME. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. J. Am. Acad. Dermatol. 51, 132–135 (2004).
17. Cohen PR. What caused this abscess and cellulitis? Diagnosis: community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) skin infection. Skin & Aging 12 (10), 56–58 (2004).
18. Cohen PR. Enlarging facial abscess with cellulitis (community-acquired methicillin-resistant Staphylococcus aureus. (Dermatology Dx). Cortlandt Forum 18 (4), 42,45 (2005).
19. Cohen PR. Enlarging facial abscess with cellulitis (community-acquired methicillin-resistant Staphylococcus aureus. (Dermatology Clinic) The Clinical Advisor 8 (9), 60,63 (2005).
20. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as a periumbilical folliculitis: case reports. Cutis 77, 229–231 (2006).
21. Young DM, Harris HW, Charlebois ED et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch. Surg. 139, 947–953 (2004).
22. Chambers HF. Community-associated MRSA – resistance and virulence converge. N. Engl. J. Med. 352, 1485–1487 (2005).
23. Crawford SE, Daum RS. Epidemic community-associated methicillin-resistant Staphylococcus aureus. Modern times for an ancient pathogen. Pediatr. Infect. Dis. J. 24, 459–460 (2005).
24. Purcell K, Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections. A 14-year study at Driscoll children’s hospital. Arch. Pediatr. Adolesc. Med. 159, 980–985 (2005).
25. Diep BA, Gill SR, Chang RF et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367, 731–739 (2006).
26. Enright MC. Genome of an epidemic community-acquired MRSA. Lancet 367, 705–706 (2006).
27. Schulz P, Allen M, Murray Q et al. Infections due to community-acquired methicillin-resistant Staphylococcus aureus: an emergent epidemic in Kentucky. J. Ky. Med. Assoc. 103 (5), 194–203 (2005).
28. Center for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison – Mississippi, 2000. MMWR 50, 919–922 (2001).
29. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns–Chicago and Los Angeles county, 2004. MMWR. 55, 329–332 (2006).
30. Zinderman CE, Conner B, Malakooti MA, Lamar JE, Armstrong A, Bohnker BK. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg. Infect. Dis. 10, 941–944 (2004).
31. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin. Infect. Dis. 29, 797–800 (1999).
32. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as an axillary abscess with cellulitis in a college athlete. SKINmed. 4, 115–118 (2005).
33. Cohen PR. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. South Med. J. 98, 596–602 (2005).
34. Cohen PR. The skin in the gym: a comprehensive review of the cutaneous manifestations of community-acquired methicillin-resistant Staphylococcus aureus in athletes. Clin. Dermatol. (In press)(2006).
35. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention. Int. J. Dermatol. (In press)(2006).
36. Dominguez TJ. It’s not a spider bite, it’s community-acquired methicillin-resistant Staphylococcus aureus. J. Am. Board Fam. Pract. 17, 220–226 (2004).
37. Official Journal of the American Academy of Pediatrics www.pediatrics.org/cgi/content/full/113/4/e347
38. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA; Participants in the CDC-Convened Experts’ Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts’ meeting convened by the Center for Disease Control and Prevention. (2006). www.ced.gov/ncidod/dhqp/ar/CAMRSA_ExpMtgStrategies.pdf.